Skip to main content

Table 3 The effectiveness, total cost, and incremental cost-effectiveness by vaccination strategy against cervical cancer due to HPV types 16 and 18

From: The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach

Number

Options

Total cost per 1000 women

Cancer per 1000 women

Cancer reduction (%)

DALY averted per 1000 women

Cost-effective ratio (cancer reduction)

Cost-effective ratio (DALY averted)

ICER (cancer reduction)

ICER (DALY averted)

1.

No vaccination with current screening

4497

3.4

-

-

-

-

-

-

2.

10 years old girls

21,599

0.7

77.9

31.1

8000

695

6334

550

3.

10 years old girls + catch-up girls aged 11–25 years old

27,807

0.4

86.8

35.1

9269

792

20,693

1559

4.

10 years old girls + boys

38,030

0.6

81.3

32.6

13,582

1167

D

D

5.

10 years old girls + catch-up girls aged 11–75 years old

39,059

0.3

91.4

37.0

12,600

1056

112,520

5840

6.

10 years old girls + boys + catch-up girls aged 11–25 years old

44,263

0.4

87.4

35.3

14,754

1254

D

D

7.

10 years old girls + boys + catch-up girls and boys aged 11–25 years old

50,210

0.4

88.7

35.9

16,737

1399

D

D

8.

10 years old girls + boys + catch-up girls aged 11–75 years old

55,520

0.3

91.4

37.0

17,910

1501

D

D

9.

10 years old girls + boys + catch-up girls and boys aged 11–75 years old

72,723

0.3

91.8

37.2

23,459

1955

D

168,320

  1. Note: The cost-effectiveness ratio was a comparison of an option and the baseline scenarios (no vaccination with current screening). The incremental cost of effectiveness ratio expressed as cancer prevented or DALY averted is listed in order of increasing cost. In non-dominant strategy, the ICER was calculated by devising different cost to different effectiveness. ICERs is comparing the option to the next best alternative option. The D refers to strong dominance, which is expressed as higher cost, but lower effectiveness than alternative options. The currency is 2013 international dollars, using purchasing power parity
  2. The GDP per capita in 2013 was about 4822 international dollars [30]